Share
- Release Date: 15/05/14 17:40
- Summary: NTA: MLN: MLN NAV $0.9238 as at 13/5/14
- Price Sensitive: No
- Download Document 1.52KB
MLN
15/05/2014 15:39
NTA
REL: 1539 HRS Marlin Global Limited
NTA: MLN: MLN NAV $0.9238 as at 13/5/14
MLN NAV $0.9238 as at 13/5/14
Date 13/5/2014 6/5/2014
MLN NAV $0.9238 $0.9153
Share price close $0.83 $0.83
Discount 10% 9%
The above NAV is unaudited and net of fees and tax.
The NAV per share is after deducting treasury stock (shares acquired under
the Marlin Global buyback programme). A performance fee payable to the
Manager is currently being accrued in the NAV.
The five largest portfolio holdings at 13 May 2014 are approximately as
follows:
Biotest (Germany) 5%
Sarine Technologies (Israel) 5%
Brembo (Italy) 4%
Wirecard (Germany) 4%
Varian Medical Systems (US) 4%
BACKGROUND
Marlin Global is a listed investment company that invests in growing
companies based outside of New Zealand and Australia. The Marlin portfolio is
managed by Fisher Funds, a specialist investment manager with a track record
of successfully investing in growth company shares. The aim of Marlin is to
offer investors competitive returns through capital growth and dividends, and
access to a diversified portfolio of investments through a single,
tax-efficient investment vehicle. Marlin listed on the NZX Main Board on 1
November 2007 and may invest in companies that are listed on any approved
stock exchange (excluding New Zealand or Australia) or unlisted companies not
incorporated in New Zealand or Australia.
For further information please contact Marlin Global Limited, ph (09) 484
0365.
End CA:00250506 For:MLN Type:NTA Time:2014-05-15 15:40:00
